New heart scan dye uses half the dose

NCT ID NCT05954559

First seen Apr 23, 2026 · Last updated Apr 23, 2026

Summary

This study is testing a new, FDA-approved MRI contrast dye called Elucirem to see if it can detect scarring in heart muscle as well as a standard dye, but using only half the dose. Researchers will compare new scans using Elucirem with old scans from the same 25 participants who previously had a standard scan. The goal is to see if the new, lower-dose agent provides equally clear pictures of heart damage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins Center for Advanced Imaging and Research Science, located in the Science + Technology Park at 1812 Ashland Avenue, Baltimore, MD.

    RECRUITING

    Baltimore, Maryland, 21202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Johns Hopkins School of Medicine

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21205, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.